mobile header

Overview

image

Chondrosarcoma is a sub-type of bone cancer that usually occurs in the bones. However, it may also develop in the surrounding soft tissues. The hip, pelvis, and shoulder bones are most commonly affected areas.

Chondrosarcomas are usually slow-growing tumors; however, some types of chondrosarcomas are aggressive and have a high risk of metastasis.

Taking On Cancer, Together !​

Life does not stop when cancer strikes.​

We are with you in this fight to win over cancer. We are here to give you the strength to recover through a comprehensive cancer care program.

Request an Appointment
Life Does Not Support

Frequently Asked Questions (FAQs)

At American Oncology Institute, the primary treatment for chondrosarcoma is surgery to remove the tumor, and depending on the case, advanced techniques and reconstruction may be used to preserve function and improve recovery.

You can book an appointment with the experts at American Oncology Institute through https://www.americanoncology.com/bookanappointment or call the 24x7 helpline number 1800 208 2000 for assistance.

Chondrosarcoma is usually resistant to chemotherapy and radiation therapy, making surgery the main treatment; however, radiation may sometimes be used in high-grade or inoperable cases to manage tumor growth.

Chondrosarcoma is a rare type of bone cancer that develops in the cartilage cells, commonly affecting the pelvis, ribs, arms, and legs, and it requires specialized oncology care for accurate diagnosis and treatment.

The most common symptoms of chondrosarcoma include persistent pain, swelling in the affected bone, restricted joint movement, and sometimes a noticeable lump, which may gradually worsen over time.

Chondrosarcoma is diagnosed using a combination of physical examination, imaging tests such as X-rays, CT scans, MRI, and a biopsy, which helps confirm the type and grade of the tumor for effective treatment planning.

American Oncology Institute offers a multidisciplinary team of expert oncologists, orthopedic surgeons, radiologists, and pathologists, ensuring personalized and comprehensive care with advanced treatment protocols for chondrosarcoma patients.

The prognosis for chondrosarcoma depends on the tumor’s grade, size, and location, with low-grade tumors having better survival rates and high-grade tumors requiring more aggressive management for improved outcomes.